AI Article Synopsis

  • Composite haemangioendothelioma is a rare vascular tumor that can exhibit low to medium malignant potential and is diagnosed by identifying different vascular components through histopathology.
  • A case study describes a 49-year-old man with chronic lymphoedema who developed this tumor, which showed high-grade angiosarcoma-like features but behaved less aggressively, confusing it with the more severe Stewart-Treves syndrome.
  • Despite needing potentially extensive surgery (hemipelvectomy), the patient opted against it and, after two years of monitoring, experienced no disease progression, indicating the need for accurate diagnosis to avoid unnecessary procedures.

Article Abstract

Background: Composite haemangioendothelioma is a rare vascular neoplasm with indolent to intermediate malignant potential. Diagnosis of this disease relays on histopathological identification of at least two different morphologically distinctive vascular components in proper clinical settings. Exceedingly rare cases of this neoplasm can exhibit areas resembling high-grade angiosarcoma, which does not change the biological behaviour. Such lesions tend to occur in the setting of chronic lymphoedema and thus, can mimic Stewart-Treves syndrome, which has a much worse clinical outcome and prognosis.

Case Presentation: We present a case of 49 years old male suffering from chronic lymphoedema of the left lower extremity who had developed a composite haemangioendothelioma with high grade angiosarcoma-like areas mimicking the Stewart-Treves syndrome. Given the multifocality of the disease, the only potentially curable surgical treatment would be hemipelvectomy, which was refused by the patient. The patient has been followed-up, with no signs of local progression of the remaining disease, nor a distant spread outside the involved extremity for two years.

Conclusions: Composite haemangioendothelioma represents a rare malignant vascular tumour, with significantly more favourable biological behaviour than angiosarcoma, even in cases where angiosarcoma-like areas are present. For that reason, composite haemangioendothelioma can be easily misdiagnosed as true angiosarcoma. The rarity of this disease unfortunately hampers the development of clinical practice guidelines and the implementation of treatment recommendations. Most of the patients with localized tumour are treated by wide surgical resection, without neo- or adjuvant radiotherapy or chemotherapy. However, in the case of this diagnosis, the watch-and-wait approach is better than mutilating procedure, highlighting the necessity of establishing of the correct diagnosis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286458PMC
http://dx.doi.org/10.1186/s13000-023-01365-1DOI Listing

Publication Analysis

Top Keywords

composite haemangioendothelioma
20
angiosarcoma-like areas
12
stewart-treves syndrome
12
mimicking stewart-treves
8
biological behaviour
8
chronic lymphoedema
8
haemangioendothelioma
5
patient composite
4
haemangioendothelioma angiosarcoma-like
4
areas
4

Similar Publications

Composite hemangioendothelioma comprises permutations of different histological patterns few of which have been found to have specific genetic alteration and immunohistochemical expression. It comprises retiform or epithelioid hemangioendothelioma-like areas, with a variable proportion of hemangioma or low-grade angiosarcoma-like areas. It was found to express neuroendocrine markers and was seen to have a worse prognosis in recurrence or distant metastasis.

View Article and Find Full Text PDF

Type and dimensions can predict ventricular arrhythmias and cardiac death in primary benign cardiac tumors in children.

Int J Cardiol

January 2025

Pediatric Cardiology and Cardiac Arrhythmias and Syncope Unit, Bambino Gesù Children's Hospital, IRCSS, 00146 Rome, Italy; European Reference Network for Low Prevalence and Rare Disease of the Heart- ERN Guard Heart, Italy. Electronic address:

Article Synopsis
  • Primary benign cardiac tumors in children are rare but can lead to serious complications like malignant ventricular arrhythmias and cardiac death.
  • A study conducted over 38 years included 97 children with various types of tumors, revealing that those with tumors larger than 2.3 cm or diagnosed with fibromas had worse health outcomes.
  • The research highlighted that 24.5% of the patients experienced clinically significant arrhythmias, suggesting that tumor type and size are important indicators of potential risks.
View Article and Find Full Text PDF

Composite hemangioendothelioma (CHE) is a rare locally aggressive vascular neoplasm of intermediate malignancy. We describe a 2-year-old patient diagnosed with this tumor. Careful documentation of patients with CHE is crucial to better define the prognosis and treatment of this entity.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!